For the quarter ending 2025-09-30, OLPX had -$2,961K decrease in cash & cash equivalents over the period. $7,931K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net sales | 114,579 | - |
| Cost of product (excluding amortization) | 32,677 | - |
| Marketing expenses | 23,414 | - |
| Adjusted selling, general, and administrative | 26,560 | - |
| Depreciation and amortization | 13,698 | - |
| Interest expense | 7,691 | - |
| Interest income | 2,690 | - |
| Tax receivable agreement liability adjustment | 9,452 | - |
| Income tax (benefit) provision | -2,427 | - |
| Share-based compensation expense | 3,311 | - |
| Other segment items | 10,670 | - |
| Net income | 11,127 | -7,277 |
| Amortization of patent formulations | 2,704 | 4,576 |
| Amortization of other intangibles | 10,905 | 21,823 |
| Inventory write-off and disposal | 677 | 2,804 |
| Depreciation of fixed assets | 89 | 179 |
| Amortization of debt issuance costs | 288 | 3,314 |
| Deferred taxes | -3,295 | -1,444 |
| Tax receivable agreement liability adjustment | 9,452 | - |
| Share-based compensation expense | 3,311 | 6,381 |
| Acquisition-related costs in investing activities | 9,282 | - |
| Other | -236 | -641 |
| Accounts receivable, net | 16,995 | 17,696 |
| Inventory | -3,961 | 5,988 |
| Prepaid expenses and other current assets | 1,090 | 49,162 |
| Accounts payable | -1,407 | 14,653 |
| Accrued expenses and other current liabilities | -2,837 | 47,863 |
| Other assets and liabilities | -498 | 2,680 |
| Net cash provided by operating activities | 8,002 | 17,987 |
| Purchase of property and equipment | 71 | 151 |
| Acquisition-related costs | 10,587 | - |
| Purchase and development of software | 305 | 1,174 |
| Net cash used in investing activities | -10,963 | -1,325 |
| Proceeds from exercise of stock options | 0 | 527 |
| Payments for shares withheld and retired to cover tax withholding obligation for rsus | - | 0 |
| Payments made pursuant to tax receivable agreement | 0 | 12,129 |
| Principal payments of 2022 term loan facility | 0 | 301,688 |
| Net cash used in financing activities | 0 | -313,290 |
| Net (decrease) increase in cash and cash equivalents | -2,961 | -296,628 |
| Cash and cash equivalents at beginning of period | 585,967 | - |
| Cash and cash equivalents at end of period | 286,378 | - |
OLAPLEX HOLDINGS, INC. (OLPX)
OLAPLEX HOLDINGS, INC. (OLPX)